[1] |
|
[2] |
Chacón-Camacho OF, Pozo-Molina G, Méndez-Catalá CF, et al. Familial hypercholesterolemia: update and review[J]. Endocr Metab Immune Disord Drug Targets, 2022, 22(2): 198-211. DOI: 10.2174/1871530321666210208212148.
|
[3] |
Rani A, Greenlaw R, Smith RA, et al. HES1 in immunity and cancer[J]. Cytokine Growth Factor Rev, 2016, 30(3): 113-117. DOI: 10.1016/j.cytogfr.2016.03.010.
|
[4] |
|
[5] |
Welty FK. Dietary treatment to lower cholesterol and triglyceride and reduce cardiovascular risk[J]. Curr Opin Lipidol, 2020, 31(4): 206-231. DOI: 10.1097/MOL.0000000000000689.
|
[6] |
Wadström BN, Pedersen KM, Wulff AB, et al. Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality[J]. Eur Heart J, 2023, 44(16): 1432-1445. DOI: 10.1093/eurheartj/ehac822.
|
[7] |
Gidding SS, Allen NB. Cholesterol and atherosclerotic cardiovascular Disease: a lifelong problem[J]. J Am Heart Assoc, 2019, 8(11): e012924. DOI: 10.1161/JAHA.119.012924.
|
[8] |
Nicholls SJ, Fujino M. HDL cholesterol and cardiovascular risk: teasing the answer from the complexity[J]. Eur J Prev Cardiol, 2023, 30(8): 644-645. DOI: 10.1093/eurjpc/zwad074.
|
[9] |
Zhang J, Wang X, Liu H, et al. TNF-α enhances apoptosis by promoting chop expression in nucleus pulposus cells: role of the MAPK and NF-κB pathways[J]. J Orthop Res, 2019, 37(3): 697-705. DOI: 10.1002/jor.24204.
|
[10] |
Zhao XW, Zhou JP, Bi YL, et al. The role of MAPK signaling pathway in formation of EMT in oral squamous carcinoma cells induced by TNF-α[J]. Mol Biol Rep, 2019, 46(3): 3149-3156. DOI: 10.1007/s11033-019-04772-0.
|
[11] |
Moujalled DM, Pomilio G, Ghiurau C, et al. Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia[J]. Leukemia, 2019, 33(4): 905-917. DOI: 10.1038/s41375-018-0261-3.
|
[12] |
Smith VM, Dietz A, Henz K, et al. Specific interactions of BCL-2 family proteins mediate sensitivity to BH3-mimetics in diffuse large B-cell lymphoma[J]. Haematologica, 2020, 105(8): 2150-2163. DOI: 10.3324/haematol.2019.220525.
|
[13] |
Liu Q, Osterlund EJ, Chi X, et al. Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2[J]. Elife, 2019, 8: e37689. DOI: 10.7554/eLife.37689.
|
[14] |
Min HK, Kook MK, Yoon SS, et al. Meiotic cell cycle progression in mouse oocytes: role of cyclins[J]. Int J Mol Sci, 2023, 24(17): 13659. DOI: 10.3390/ijms241713659.
|
[15] |
Li W, Huang Z, Fang W, et al. Remnant cholesterol variability and incident ischemic stroke in the general population[J]. Stroke, 2022, 53(6): 1934-1941. DOI: 10.1161/STROKEAHA.121.037756.
|
[16] |
Lee M, Cheng CY, Wu YL, et al. Association between intensity of low-density lipoprotein cholesterol reduction with statin-based therapies and secondary stroke prevention: a meta-analysis of randomized clinical trials[J]. JAMA Neurol, 2022, 79(4): 349-358. DOI: 10.1001/jamaneurol.2021.5578.
|
[17] |
Wang X, Dong Y, Qi X, et al. Cholesterol levels and risk of hemorrhagic stroke: a systematic review and meta-analysis[J]. Stroke, 2013, 44(7): 1833-1839. DOI: 10.1161/STROKEAHA.113.001326.
|
[18] |
Wadström BN, Wulff AB, Pedersen KM, et al. Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study[J]. Eur Heart J, 2022, 43(34): 3258-3269. DOI: 10.1093/eurheartj/ehab705.
|
[19] |
|